The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of TCHL-based therapy on immune cell content in on-treatment, neoadjuvant-treated HER2-positive breast cancer patients.
 
Niamh M. Keegan
Travel, Accommodations, Expenses - Roche
 
Sinead Toomey
Travel, Accommodations, Expenses - Pfizer
 
Joanna Fay
No Relationships to Disclose
 
Stephen F. Madden
No Relationships to Disclose
 
Bruce Moran
Employment - OncoMark
 
Malgorzata Milewska
No Relationships to Disclose
 
Sudipto Das
No Relationships to Disclose
 
Darran O'Connor
Honoraria - Novartis
Consulting or Advisory Role - Pfizer
 
M. John Kennedy
No Relationships to Disclose
 
Colm Power
No Relationships to Disclose
 
Arnold D. Hill
No Relationships to Disclose
 
Keith Egan
No Relationships to Disclose
 
Ausra Teiserskiene
No Relationships to Disclose
 
Elaine Kay
Consulting or Advisory Role - Almac Diagnostics
 
John Crown
Honoraria - Eisai; Genomic Health; Teva
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Eisai; NEO New Oncology; Novartis; Pfizer; Pierre Fabre; Vertex
Research Funding - Boehringer Ingelheim (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Roche (Inst)
 
Alex J Eustace
Speakers' Bureau - Roche
Research Funding - Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Bryan Hennessy
No Relationships to Disclose